| Tag | Content |
|---|
EnhancerAtlas ID | HS032-00302 |
Organism | Homo sapiens |
Tissue/cell | DLD1 |
Coordinate | chr12:123734940-123736790 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFE2L1 | MA0089.2 | chr12:123735629-123735644 | TCTGCTGAGTCATGC | - | 7.23 | | Nfe2l2 | MA0150.2 | chr12:123735631-123735646 | TGCTGAGTCATGCAG | - | 7.41 | | RREB1 | MA0073.1 | chr12:123736160-123736180 | TGGGGGGGTGTGTGTTCGGG | - | 6.14 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_13718 | chr12:123735330-123736488 | CD34_Primary_RO01536 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr12 | 123736311 | 123736577 | | chr12 | 123735107 | 123736146 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I123250 | chr12 | 123734884 | 123737119 |
|
Enhancer Sequence | TTTGGATCCA TTGCCAGTGA ACTAGTATGT TTTTTGGGGG GTGTTGAAGC GTCTTGTTTT 60
GTCATATTAC CAGGGTTTGT TCATTTGGGT AGGCTCTGTC AGAGGGAAGG TCTAGGGCTG 120
AAGGCTGTTC AGATTCTTTT GTCCCATGGG GTGTTCTCTT CATGTAGTAC TCTGCCCCTT 180
TTCCTATGGA TGTGGCTTCC TATGAGCCAA ACTTGCAGTG ATTGTTGTCT CTCTTCTGGG 240
TCTAGCCACC CAGCGAATCT TCCCAGTTCC AGGCTGGTAC TGGAGGTTAT CTGCAGAGTC 300
CTGTGATGTG AACCATCTAT GGGTCTCTCA GCCATGGCTA CCAGTGCCTG TTCGGTGGAG 360
GTGGCAGAGG GTACAATGGA GCTTTGGTGG GTTAATGGTC TATTTTTTTT GCTGGTTGGC 420
CTCCTGCCAG GAGGTGGTCC TTTCCAGAAA GCATCAGCTG TGGTAATATG GGGAGGAACC 480
AGCAGTGGGC GGGGCCCTAG AACTCCCAAG ATTTATTTGC CCTTTGTCTT CCTGCCAGGG 540
TGCATAGGGA AGGACCATCA GGTGGGGGTG GAGCTAGGCG TGTCTGAGCT CAGACTCTCC 600
TTGGGCGGGT CTTGCTGCGG CTGCTGTAGG GAATGTGGGT GAGATTCCCA GGTCACTGGA 660
GTCGTGTACC TAGGAGAGTT ATGGCTGCCT CTGCTGAGTC ATGCAGGTTG TCAGGGAAGT 720
GGGGGAAAGC TGGCAGTCAC AGGCCTCACC CAGCTCCCAC ACAAACCCAA GGGCCGGTCT 780
TACTCCCACC GTGTTCCCCC ACAACTGCCC CGAGTCTGTT TCCAGGCAGA GGGTGAGACT 840
GGCTTGAAAA TTTGCCCCAA GGCTGTGCCC CTCCCAGCAG CGAAAGAAAA GGGCTGTAGT 900
TCTTCCCCCA CCTGTGAAGT CTGCATGCTG GATTCGTGCA GTTGCCCAAG TTCTGGCCAG 960
GAGGCTTCTC ACCCTGTTTA AATTGTTACG AAGTTCGACT AGAGAATTCT TCTCCCTGTG 1020
GAGTTTTATC CCTTGCTCCT CTGGCCACCC TCCCGATGGA TCCCTGTGGT GCCAGGCAGG 1080
AATGGGCCTT CTGGGGACCC AGCGAGCTCC CACGGCCTTT CTGCTGCTTC CTCTACCCCT 1140
GTAGTTCGCT CTGCTGAGTC TGACTTAGCT CCAGGTAAAG TTGGAAATTT CTCCTGCAAA 1200
CAGACCTTCA GCCTCTCCAG TGGGGGGGTG TGTGTTCGGG AGAGGAGGAT CTCCCTTTCC 1260
CACTTCCACA GTTGGGGCAC TCACAGTATT TGGGGGTCTC CCGGGCCCTG CAGGAGCAAT 1320
CCGCTTCCTT CAGAGGGTCT GTGGGTCCTC TCAGGATTGC TGGTTTGTTC TTGCAGTTGA 1380
TCTAGAGCTA AAATTCACAA TGCAAGCCTC TGCATGCTGC TCTGTCTGAA GCTACAATCT 1440
AGTCCTGCCT CCTGTCTGCT ATGATCCCAG GAGCTCCCAT GCAAATAAAT TATGATCACA 1500
AGGTCCCAAA ATAGGCTGTC TAGAGCTGAG GAGCAAGGAG AGCCAGTCTG AGTCCCAAAA 1560
CTGAAGAACG TGGAGTCTGA TGTTCAAGGG CAGGGAGCAT CCAGCACTGG AGAAAGATGT 1620
AGGCAGAGAG TCTAGGCCCA TCTCATCTGT CTTTTAATAT CTTCTCTAAC TAACCTGTAA 1680
GCTCCAAGAA GACAGTCCAG CTCTTTTTCA TCTCATGTCC CTTACTGTAC CTAACAAGGA 1740
CCTTATTAAA AGTTGACTGG CTGGATGCAG TGGCTCACGC CTGTAATCCC AGAACTTTGG 1800
GAGGCTGAAG CAGGTGGATT ACTTGACCTT AGGGAGTTCA AGACCAGCCT 1850
|
